CHMFL-ABL-039

• Description:

  CHMFL-ABL-039 is a type II native ABL kinase and drug-resistant V299L mutant BCR-ABL inhibitor (IC50s: 7.9 nM and 27.9 nM) used in the research of chronic myeloid leukemia.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  594.639

• Molecular Formula:

  C31H33F3N6O3

• Notes:

  Research use only, not for human use.

• Receptor:

  Apoptosis| DUSP6

• CAS Number:

  2304344-56-5